371 results on '"Burgener, Adam"'
Search Results
2. Update on the Impact of Depot Medroxyprogesterone Acetate on Vaginal Mucosal Endpoints and Relevance to Sexually Transmitted Infections
3. Gut-derived bacterial toxins impair memory CD4 T-cell mitochondrial function in HIV-1 infection
4. Increased genital mucosal cytokines in Canadian women associate with higher antigen-presenting cells, inflammatory metabolites, epithelial barrier disruption, and the depletion of L. crispatus
5. Mass spectrometry analysis of gut tissue in acute SIV-infection in rhesus macaques identifies early proteome alterations preceding the interferon inflammatory response
6. Copper intrauterine device increases vaginal concentrations of inflammatory anaerobes and depletes lactobacilli compared to hormonal options in a randomized trial
7. A Description of the THRIVE (“The Study of Host-Bacterial Relationships in Different Vaginal Environments”) Bacterial Vaginosis Observational Study
8. Systems analysis reveals differential expression of endocervical genes in African women randomized to DMPA-IM, LNG implant or cu-IUD
9. The neovaginal microbiome of transgender women post-gender reassignment surgery
10. Vaginal epithelial dysfunction is mediated by the microbiome, metabolome, and mTOR signaling
11. Pregnancy associates with alterations to the host and microbial proteome in vaginal mucosa
12. Pregnancy associates with alterations to the host and microbial proteome in vaginal mucosa.
13. Increased mucosal neutrophil survival is associated with altered microbiota in HIV infection.
14. Acute Infection and Subsequent Subclinical Reactivation of Herpes Simplex Virus 2 after Vaginal Inoculation of Rhesus Macaques
15. Gut microbiome signatures linked to HIV-1 reservoir size and viremia control
16. Lactic acid from vaginal microbiota enhances cervicovaginal epithelial barrier integrity by promoting tight junction protein expression
17. Estradiol-mediated enhancement of the human ectocervical epithelial barrier correlates with desmoglein-1 expression in the follicular menstrual phase.
18. Highly Human Immunodeficiency Virus-Exposed Seronegative Men Have Lower Mucosal Innate Immune Reactivity
19. Treatment with Commonly Used Antiretroviral Drugs Induces a Type I/III Interferon Signature in the Gut in the Absence of HIV Infection
20. The relationship between intra-amniotic sludge and the amniotic fluid proteome in a cohort of pregnant women with acute cervical insufficiency.
21. Microbiome Composition and Function Drives Wound-Healing Impairment in the Female Genital Tract.
22. Intestinal proteomic analysis of a novel non-human primate model of experimental colitis reveals signatures of mitochondrial and metabolic dysfunction
23. HIV Transmission in Female Commercial Sex Workers and Host Protective Factors
24. Influence of dapivirine vaginal ring use on cervicovaginal immunity and functional microbiome in adolescent girls
25. Semen-mediated enhancement of HIV infection is donor-dependent and correlates with the levels of SEVI
26. Vaginal bacteria modify HIV tenofovir microbicide efficacy in African women
27. Genital Injury Signatures and Microbiome Alterations Associated With Depot Medroxyprogesterone Acetate Usage and Intravaginal Drying Practices
28. Impact of Q-Griffithsin anti-HIV microbicide gel in non-human primates: In situ analyses of epithelial and immune cell markers in rectal mucosa
29. Using safe, affordable and accessible non-steroidal anti-inflammatory drugs to reduce the number of HIV target cells in the blood and at the female genital tract
30. The Relationship between Intra-Amniotic Sludge and the Amniotic Fluid Proteome in a Cohort of Pregnant Women with Acute Cervical Insufficiency: A Pilot Study
31. Non-optimal bacteria species induce neutrophil-driven inflammation and barrier disruption in the female genital tract
32. Non-Lactobacillus-Dominant and Polymicrobial Vaginal Microbiomes Are More Common in Younger South African Women and Predictive of Increased Risk of Human Immunodeficiency Virus Acquisition
33. Pre-clinical evaluation of antiproteases as potential candidates for HIV-1 pre-exposure prophylaxis
34. Initiating Intramuscular Depot Medroxyprogesterone Acetate Increases Frequencies of Th17-like Human Immunodeficiency Virus Target Cells in the Genital Tract of Women in South Africa: A Randomized Trial
35. Lactic acid from vaginal microbiota enhances cervicovaginal epithelial barrier integrity by promoting tight junction protein expression
36. Nonoptimal bacteria species induce neutrophil-driven inflammation and barrier disruption in the female genital tract.
37. Impact of the griffithsin anti-HIV microbicide and placebo gels on the rectal mucosal proteome and microbiome in non-human primates
38. Increased genital mucosal cytokines in Canadian women associates with increased antigen presenting cells, inflammatory metabolites, epithelial barrier disruption and the depletion of L. crispatus
39. Non-Lactobacillus-Dominant and Polymicrobial Vaginal Microbiomes Are More Common in Younger South African Women and Predictive of Increased Risk of Human Immunodeficiency Virus Acquisition.
40. The Effect of Contraception on Genital Cytokines in Women Randomized to Copper Intrauterine Device, Depot Medroxyprogesterone Acetate, or Levonorgestrel Implant
41. Additional file 1 of Lactic acid from vaginal microbiota enhances cervicovaginal epithelial barrier integrity by promoting tight junction protein expression
42. Additional file 2 of Gut microbiome signatures linked to HIV-1 reservoir size and viremia control
43. Comparative analysis of DNA extraction and PCR product purification methods for cervicovaginal microbiome analysis using cpn60 microbial profiling
44. HIV Transmission in Female Commercial Sex Workers and Host Protective Factors
45. Corrigendum: Complement-Opsonized HIV Modulates Pathways Involved in Infection of Cervical Mucosal Tissues: A Transcriptomic and Proteomic Study
46. An updated review on the effects of depot medroxyprogesterone acetate on the mucosal biology of the female genital tract
47. The Female Reproductive Tract Microbiome—Implications for Gynecologic Cancers and Personalized Medicine
48. Complement-Opsonized HIV Modulates Pathways Involved in Infection of Cervical Mucosal Tissues: A Transcriptomic and Proteomic Study
49. Correction: Complement-Opsonized HIV Modulates Pathways Involved in Infection of Cervical Mucosal Tissues : A Transcriptomic and Proteomic Study (vol 12, 625649, 2021)
50. The impact of progestin-based contraceptive initiation on the cervicovaginal proteome and its relationship with HIV acquisition in the ECHO trial
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.